Hipovastin en es it fr

Hipovastin Brand names, Hipovastin Analogs

Hipovastin Brand Names Mixture

  • No information avaliable

Hipovastin Chemical_Formula


Hipovastin RX_link


Hipovastin fda sheet

Hipovastin FDA

Hipovastin msds (material safety sheet)

Hipovastin Synthesis Reference

R. L. Monaghan et al., U.S. Pat. 4,231,938 (1980)

Hipovastin Molecular Weight

404.54 g/mol

Hipovastin Melting Point

174.5 oC

Hipovastin H2O Solubility

0.0004 mg/mL

Hipovastin State


Hipovastin LogP


Hipovastin Dosage Forms


Hipovastin Indication

For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease

Hipovastin Pharmacology

Lovastatin, an antilipemic agent produced by fermentation of Aspergillus terreus, is the first of a class of lipid-lowering agents known as the HMG-CoA reductase inhibitors. Lovastatin is used to treat hypercholesterolemia, to slow coronary atherosclerosis, and to prevent myocardial infarction and stroke. Lovastatin, like simvastin and unlike pravastatin, is a prodrug, concentrating active drug in the liver during first-pass circulation.

Hipovastin Absorption


Hipovastin side effects and Toxicity

LD50>1000 mg/kg (orally in mice)

Hipovastin Patient Information


Lovastatin is used to lower high cholesterol levels. This medication should
not be taken if you are pregnant, nursing, or have liver disease. Lovastatin
should be taken with the evening meal. This medication may cause increased
sensitivity to sunlight. Use sunscreens and wear protective clothing until
degree of sensitivity is determined. Notify your physician if you develop
blurred vision; skin rash; muscle pain, weakness, or cramps; unexplained fever,
or yellowing of the skin or eyes.

Patients should be advised about substances they should not take concomitantly
with lovastatin and be advised to report promptly unexplained muscle pain,
tenderness, or weakness (see list below and WARNINGS, Myopathy/Rhabdomyolysis ).
Patients should also be advised to inform other physicians prescribing a new
medication that they are taking MEVACOR .

Hipovastin Organisms Affected

Humans and other mammals